Items
Creator is exactly
Polina Ivanova 7 MIN READ
-
2020-11-11Russian-developed COVID-19 Vaccine Interim Trial Reports 92% Success Rate
Following initial findings of Pfizer's vaccine being effective in preventing COVID-19 infection in more than 90% of people, Russia says its vaccine has 92% efficacy according to preliminary findings in stage three of the clinical trials. The trial results are based on 20 confirmed COVID-19 cases.